Cargando…

Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study

Detalles Bibliográficos
Autores principales:	Sanz-Linares, Gabriela, Mussetti, Alberto, Albasanz-Puig, Adaia, Salvador-Corre, Iñaki, Sureda, Anna, Gudiol, Carlota, Salazar, Ramon, Marin, Mar, García Martín, Margarita, Navarro, Valentin, De la Haba, Irma, Coma, Eva, Dura, Xavier, Fontanals, Sandra, Serrano, Gala, Cruz, Claudia, Mañez, Rafael, Moreno-González, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665237/ http://dx.doi.org/10.1182/blood-2022-159213

Ejemplares similares

A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
por: Moreno-González, G., et al.
Publicado: (2021)

Handling the COVID-19 pandemic in the oncological setting
por: Mussetti, Alberto, et al.
Publicado: (2020)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
por: Salas, Maria Queralt, et al.
Publicado: (2022)

Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance
por: Gudiol, Carlota, et al.
Publicado: (2021)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting
por: Condom, Maria, et al.
Publicado: (2021)

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival
por: Mussetti, Alberto, et al.
Publicado: (2020)

327P COVID-19 in patients with oncohematologic diseases in Kazakhstan
por: Dushimova, Z., et al.
Publicado: (2020)

COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients
por: Mercolini, Federico, et al.
Publicado: (2022)

Identification of platelet refractoriness in oncohematologic patients
por: Ferreira, Aline Aparecida, et al.
Publicado: (2011)

Biosensors in Clinical Practice: Focus on Oncohematology
por: Fracchiolla, Nicola S., et al.
Publicado: (2013)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
por: Bug, Dmitrii S., et al.
Publicado: (2021)

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2019)

Baricitinib for COVID-19: a suitable treatment?
por: Favalli, Ennio G, et al.
Publicado: (2020)

Analysis of the -398C/T polymorphism in the perforin gene in oncohematological patients
por: Garcia, Fernanda Bernadelli, et al.
Publicado: (2011)

Transition of care in pediatric oncohematology: a systematic literature review
por: Strini, Veronica, et al.
Publicado: (2020)

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022)

Acute invasive fungal rhinosinusitis in pediatric patients with oncohematological diseases
por: Rodrigues, Lorrane Caroline Braga, et al.
Publicado: (2022)

Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach
por: Bondeelle, Louise, et al.
Publicado: (2021)

Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2022)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

Pharmacokinetics of baricitinib in critically ill COVID-19 patients
por: Massart, Nicolas, et al.
Publicado: (2023)

Diagnostics of Torsade de Pointes in an oncohematology patient: A case report
por: Bilmakhanbetova, Ainur, et al.
Publicado: (2021)

Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
por: Lendak, Dajana, et al.
Publicado: (2021)

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2021)

Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19
por: Corona De Lapuerta, Magdalena, et al.
Publicado: (2021)

P1575: TIKSAGEVIMAB/TSILGAVIMAB: EXPERIENCE OF USE FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19 IN ADULT PATIENTS WITH ONCOHEMATOLOGICAL DISEASES
por: Chebykina, Daria, et al.
Publicado: (2023)

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator
por: Lepe-Zuniga, Jose L., et al.
Publicado: (2018)

Fournier’s Gangrene in Patients with Oncohematological Diseases: A Systematic Review of Published Cases
por: Creta, Massimiliano, et al.
Publicado: (2021)

PB2184: COURSE OF CORONAVIRUS INFECTION IN ONCOHEMATOLOGICAL PATIENTS IN THE POST-TRANSPLANT PERIOD
por: Grishina, E., et al.
Publicado: (2022)

Baricitinib for COVID-19: a suitable treatment? – Authors' reply
por: Richardson, Peter J, et al.
Publicado: (2020)

Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
por: Goletti, Delia, et al.
Publicado: (2021)

NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19
Publicado: (2021)

Current Status of Baricitinib as a Repurposed Therapy for COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2021)

Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology
por: Cesaro, Simone, et al.
Publicado: (2022)

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions
por: Bianchi, Juliana Vieira dos Santos, et al.
Publicado: (2012)

Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies
por: Fiore, Marco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vqdn91eaot3au2bgrr4ci71hd5